81 related articles for article (PubMed ID: 29533344)
21. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of maximum standardized uptake value (SUVmax) on 18F-FDG PET/CT in patients with locally advanced or metastatic pancreatic cancer.
Moon SY; Joo KR; So YR; Lim JU; Cha JM; Shin HP; Yang YJ
Clin Nucl Med; 2013 Oct; 38(10):778-83. PubMed ID: 24107806
[TBL] [Abstract][Full Text] [Related]
23. O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
Sweeney R; Polat B; Samnick S; Reiners C; Flentje M; Verburg FA
Ann Nucl Med; 2014 Feb; 28(2):154-62. PubMed ID: 24272067
[TBL] [Abstract][Full Text] [Related]
24.
Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
26. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.
Mellon EA; Jin WH; Frakes JM; Centeno BA; Strom TJ; Springett GM; Malafa MP; Shridhar R; Hodul PJ; Hoffe SE
Acta Oncol; 2017 Mar; 56(3):391-397. PubMed ID: 27885876
[TBL] [Abstract][Full Text] [Related]
27. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
[TBL] [Abstract][Full Text] [Related]
29. [18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy.
Martoni AA; Fanti S; Zamagni C; Rosati M; De Iaco P; D'Errico Grigioni A; Castellucci P; Quercia S; Musto A; Ricci Maccarini L; Lopci E; Bernardi A
Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):81-90. PubMed ID: 21068714
[TBL] [Abstract][Full Text] [Related]
30. JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient Survival.
Marcus C; Wray R; Taghipour M; Marashdeh W; Ahn SJ; Mena E; Subramaniam RM
AJR Am J Roentgenol; 2016 Aug; 207(2):257-65. PubMed ID: 27447341
[TBL] [Abstract][Full Text] [Related]
31. The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.
Shi D; Cai G; Peng J; Li D; Li X; Xu Y; Cai S
BMC Cancer; 2015 Dec; 15():991. PubMed ID: 26689966
[TBL] [Abstract][Full Text] [Related]
32. Preoperative 18F-FDG PET/CT predicts disease-free survival in patients with primary invasive ductal breast cancer.
Jo JE; Kim JY; Lee SH; Kim S; Kang T
Acta Radiol; 2015 Dec; 56(12):1463-70. PubMed ID: 25406431
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer.
Ong LT; Dunphy M; Foster A; Woo KM; Zhang Z; Perez CA; Pietanza CM; Rosenzweig KE; Gelblum DY; Rimner A; Wu AJ
Clin Lung Cancer; 2016 May; 17(3):184-8. PubMed ID: 26320828
[TBL] [Abstract][Full Text] [Related]
34. Relationship Between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer.
Fujii T; Yanai K; Tokuda S; Nakazawa Y; Kurozumi S; Obayashi S; Yajima R; Hirakata T; Shirabe K
Anticancer Res; 2018 Aug; 38(8):4927-4931. PubMed ID: 30061271
[TBL] [Abstract][Full Text] [Related]
35. Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary origin.
Algin E; Ozet A; Gumusay O; Cetin B; Akdemir UO; Benekli M; Coskun U; Uner A; Kapucu O; Buyukberber S
Ann Nucl Med; 2014 Nov; 28(9):891-6. PubMed ID: 25270711
[TBL] [Abstract][Full Text] [Related]
36. Basal ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer.
García Vicente AM; Soriano Castrejón Á; López-Fidalgo JF; Amo-Salas M; Muñoz Sanchez Mdel M; Álvarez Cabellos R; Espinosa Aunión R
Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1804-13. PubMed ID: 26156534
[TBL] [Abstract][Full Text] [Related]
37. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
[TBL] [Abstract][Full Text] [Related]
38. Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
Lee SH; Ha S; An HJ; Lee JS; Han W; Im SA; Ryu HS; Kim WH; Chang JM; Cho N; Moon WK; Cheon GJ
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1574-84. PubMed ID: 27209424
[TBL] [Abstract][Full Text] [Related]
39. Relationship among glycolytic phenotype, grade, and histological subtype in ovarian carcinoma.
Karantanis D; Allen-Auerbach M; Czernin J
Clin Nucl Med; 2012 Jan; 37(1):49-53. PubMed ID: 22157028
[TBL] [Abstract][Full Text] [Related]
40. SUVmax on FDG-PET is a predictor of prognosis in patients with maxillary sinus cancer.
Doi H; Kitajima K; Fukushima K; Kawanaka Y; Mouri M; Yamamoto S; Ishikura R; Terada T; Noguchi K; Hirota S
Jpn J Radiol; 2016 May; 34(5):349-55. PubMed ID: 26920841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
